Company Description
Docola aims to be a social good organization offering a free care communication platform that seeks to consolidate thousands of free and low-cost patient education resources from the leading nonprofit, government, and commercial organizations in one online marketplace called Docola.
Additionally, our Platform allows users to easily create and upload their own resources. With the use of our Platform, clinicians and patient-facing professionals can ePrescribe personalized information to an individual patient or groups of patients.
Patients can review the information and ask questions in the comfort of their own homes before, between, or after in-person or virtual visits.
We aim to enable healthcare providers to proactively meet people’s health informational needs, so they understand why it is important, possible, and safe to participate in their own medical care.
We aim to save time both for the patient and provider and improve patient satisfaction and patient outcomes.
To support the free version of the Platform, we offer optional paid services and license a separate product called DocolaRx, to research organizations, medical devices, biotech and pharmaceutical companies for their projects.
| Country | United States |
| Founded | 2013 |
| Industry | Internet Content & Information |
| Sector | Communication Services |
| Employees | 1 |
| CEO | Eran Kabakov |
Contact Details
Address: 801 W. Bay Drive #506 Largo, FL 33770 United States | |
| Phone | (888) 981-8111 |
| Website | doco.la |
Stock Details
| Ticker Symbol | DOCO |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001644515 |
| Employer ID | 46-3626795 |
| SIC Code | 7374 |
Key Executives
| Name | Position |
|---|---|
| Eran Kabakov | Chief Executive Officer, President |
| Itay Tsabari | Chief Financial Officer |
| Tomer Kabakov | Chief Operating Officer and Director |
| Jonathan Ascher | Chief Medical Officer |
| Geri Lynn Baumblatt | Chief Engagement Officer |
| Alexander Ellis | Chief Technology Officer |
| Virginia Smith | Independent Director |
| Jean Anne Booth | Independent Director |
| Prasad Tare | Independent Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 28, 2024 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Jul 18, 2024 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Jun 20, 2024 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| May 13, 2024 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Feb 1, 2024 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Jan 2, 2024 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Dec 21, 2023 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Dec 20, 2023 | 8-A12B | Registration of securities |
| Nov 20, 2023 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Oct 10, 2023 | S-1 | General form for registration of securities under the Securities Act of 1933 |